Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

The closing price of Soleno Therapeutics Inc (NASDAQ: SLNO) was $78.71 for the day, down -3.05% from the previous closing price of $81.19. In other words, the price has decreased by -$3.05 from its previous closing price. On the day, 1.78 million shares were traded. SLNO stock price reached its highest trading level at $83.42 during the session, while it also had its lowest trading level at $77.73.

Ratios:

Our analysis of SLNO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.01 and its Current Ratio is at 15.13. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on June 23, 2025, initiated with a Buy rating and assigned the stock a target price of $110.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 01 ’25 when Hirano Patricia C sold 3,830 shares for $82.76 per share. The transaction valued at 316,971 led to the insider holds 13,206 shares of the business.

PATRICIA HIRANO bought 3,830 shares of SLNO for $316,971 on Jul 01 ’25. On Jun 24 ’25, another insider, Hirano Patricia C, who serves as the insider of the company, sold 266 shares for $84.25 each. As a result, the insider received 22,410 and left with 17,036 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLNO now has a Market Capitalization of 4151708416 and an Enterprise Value of 3854327296. For the stock, the TTM Price-to-Sale (P/S) ratio is 127.12 while its Price-to-Book (P/B) ratio in mrq is 16.53.

Stock Price History:

The Beta on a monthly basis for SLNO is -2.68, which has changed by 0.7144413 over the last 52 weeks, in comparison to a change of 0.18634176 over the same period for the S&P500. Over the past 52 weeks, SLNO has reached a high of $90.32, while it has fallen to a 52-week low of $41.50. The 50-Day Moving Average of the stock is -4.23%, while the 200-Day Moving Average is calculated to be 25.95%.

Shares Statistics:

SLNO traded an average of 1.08M shares per day over the past three months and 1104010 shares per day over the past ten days. A total of 50.44M shares are outstanding, with a floating share count of 44.22M. Insiders hold about 16.17% of the company’s shares, while institutions hold 91.67% stake in the company. Shares short for SLNO as of 1752537600 were 5866108 with a Short Ratio of 5.42, compared to 1749772800 on 4063932. Therefore, it implies a Short% of Shares Outstanding of 5866108 and a Short% of Float of 12.709999999999999.

Revenue Estimates

For the next quarter, 8 analysts are estimating revenue of $62M. There is a high estimate of $83M for the next quarter, whereas the lowest estimate is $40.2M.

Based on 9 analysts’ estimates, the company’s revenue will be $378.56M in the next fiscal year. The high estimate is $551.75M and the low estimate is $230.47M.